New heart device tested in humans for first time
NCT ID NCT06840509
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests the safety and performance of a new implantable defibrillator (the CorSky ICD) in 52 people who need one for heart failure or dangerous fast heart rhythms. Participants will be followed for 12 months to check for device-related problems. The device is programmed to each person's medical needs.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CorSky ICD or CRT-D device
- What this could lead to
- If successful, this could lead to a new, safe option for implantable defibrillators that help control dangerous heart rhythms in people with heart failure.
- What could go wrong
- This is a very early, small study (52 people) focused only on safety and device function. It does not test whether the device improves health outcomes, and device-related complications are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Princess Alexandra Hospital
Brisbane, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could continuing a common heart drug before surgery save lives?
- Poles apart? nordic walking may outpace standard rehab for heart failure
- Could a gentler tug on the Heart's reins spark recovery?
- Can slow breathing soothe a failing heart?
- Can shedding pounds reboot the Heart's exercise engine?